Takara Bio USA, Inc. Launches Certified Service Provider Program to Advance Research Using NGS and Single-Cell Technologies

Takara Bio USA, Inc. announces the launch of the Takara Bio Certified Service Provider (CSP) Program, which equips service providers to conduct customer experiments using advanced NGS and single-cell technologies from Takara Bio, such as the Shasta Single Cell System, a high-throughput single-cell analysis platform. 

Admera Health, a leading provider of NGS services, is recognised as the first organisation to receive certification on the Shasta system, which positions Admera at the forefront of the single-cell genomics industry. 

According to Towards Healthcare, the buoyancy activated cell sorting (BACS) market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 208.68 million in 2026 to approximately USD 616.97 million by 2035, representing a compound annual growth rate (CAGR) of 12.8% from 2026 to 2035. Growth is driven by the increasing demand for advanced cell analysis tools in biomedical research and drug screening, leading to the need for more precise and efficient cell separation techniques. It transforms the landscape of cell sorting technologies, making them more accessible and effective for various applications. 

Partnering to push research boundaries 

Takara Bio CSP Program is a research organisation that can expect official certification and recognition, marketing exposure, and the ability to attract new clients with validated services. It gains early access to upcoming Shasta technologies, ensuring priority evaluation and incorporation of new chemistries and workflows into their service offerings.  

Shasta workflows provide large-scale single-cell NGS library preparation and data analysis using a sophisticated dispensing and imaging platform, well-validated chemistries, and end-to-end software, including the powerful Cogent bioinformatics tools. 

CEO of Admera Health said, Admera is proud to be Takara Bio’s first certified service provider, giving our clients access to our world-class team of scientists who have mastered premier technologies to accelerate breakthroughs. 

Shasta workflows provide large-scale single-cell NGS library preparation and data analysis using a sophisticated dispensing and imaging platform, well-validated chemistries, and end-to-end software, including the powerful Cogent bioinformatics tools. 

A recent report by Towards Healthcare highlights that the buoyancy activated cell sorting (BACS) market is witnessing growth driven by the adoption of this technique in biopharmaceutical and research applications, the ongoing advancements in biomedical research, and the expanding trend towards precision medicine and personalised healthcare.  

North America is dominated by the region, driven by technological advancements, increasing demand for precision cell separation, and expanding applications across biomedical research, clinical diagnostics, and biopharmaceutical manufacturing.  

The Asia Pacific market is anticipated to witness the highest growth, particularly in the biomedical research, drug screening, and clinical diagnosis sectors.